These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model. Jia Y, Yin Y, Duan F, Fu H, Hu M, Gao Y, Pan Z, Jiao X. Int J Mol Med; 2012 Dec; 30(6):1335-42. PubMed ID: 23027427 [Abstract] [Full Text] [Related]
3. A Genetically Modified attenuated Listeria Vaccine Expressing HPV16 E7 Kill Tumor Cells in Direct and Antigen-Specific Manner. Jia YY, Tan WJ, Duan FF, Pan ZM, Chen X, Yin YL, Jiao XA. Front Cell Infect Microbiol; 2017 Dec; 7():279. PubMed ID: 28706878 [Abstract] [Full Text] [Related]
4. Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice. Gomez-Gutierrez JG, Elpek KG, Montes de Oca-Luna R, Shirwan H, Sam Zhou H, McMasters KM. Cancer Immunol Immunother; 2007 Jul; 56(7):997-1007. PubMed ID: 17146630 [Abstract] [Full Text] [Related]
8. Enhanced anti-tumor effects of HPV16E7(49-57)-based vaccine by combined immunization with poly(I:C) and oxygen-regulated protein 150. Chen S, Ou R, Tang J, Deng X, Wu Y, van Velkinburgh JC, Ni B, Xu Y. Cancer Epidemiol; 2013 Apr; 37(2):172-8. PubMed ID: 23127963 [Abstract] [Full Text] [Related]
9. A novel "priming-boosting" strategy for immune interventions in cervical cancer. Liao S, Zhang W, Hu X, Wang W, Deng D, Wang H, Wang C, Zhou J, Wang S, Zhang H, Ma D. Mol Immunol; 2015 Apr; 64(2):295-305. PubMed ID: 25575128 [Abstract] [Full Text] [Related]
10. Long-lasting immunoprotective and therapeutic effects of a hyperstable E7 oligomer based vaccine in a murine human papillomavirus tumor model. Cerutti ML, Alonso LG, Tatti S, de Prat-Gay G. Int J Cancer; 2012 Apr 15; 130(8):1813-20. PubMed ID: 21780110 [Abstract] [Full Text] [Related]
11. Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin. Hsieh CJ, Kim TW, Hung CF, Juang J, Moniz M, Boyd DA, He L, Chen PJ, Chen CH, Wu TC. Vaccine; 2004 Sep 28; 22(29-30):3993-4001. PubMed ID: 15364449 [Abstract] [Full Text] [Related]
12. Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity. Cheng WF, Lee CN, Su YN, Chai CY, Chang MC, Polo JM, Hung CF, Wu TC, Hsieh CY, Chen CA. Cancer Gene Ther; 2006 Sep 28; 13(9):873-85. PubMed ID: 16645621 [Abstract] [Full Text] [Related]
14. Long-term protection against human papillomavirus e7-positive tumor by a single vaccination of adeno-associated virus vectors encoding a fusion protein of inactivated e7 of human papillomavirus 16/18 and heat shock protein 70. Zhou L, Zhu T, Ye X, Yang L, Wang B, Liang X, Lu L, Tsao YP, Chen SL, Li J, Xiao X. Hum Gene Ther; 2010 Jan 28; 21(1):109-19. PubMed ID: 19715402 [Abstract] [Full Text] [Related]
15. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells. Baghban Rahimi S, Mohebbi A, Vakilzadeh G, Biglari P, Razeghi Jahromi S, Mohebi SR, Shirian S, Gorji A, Ghaemi A. Arch Virol; 2018 Mar 28; 163(3):587-597. PubMed ID: 29149434 [Abstract] [Full Text] [Related]
17. Vaccination of full-length HPV16 E6 or E7 protein inhibits the growth of HPV16 associated tumors. Li YL, Qiu XH, Shen C, Liu JN, Zhang J. Oncol Rep; 2010 Nov 28; 24(5):1323-9. PubMed ID: 20878127 [Abstract] [Full Text] [Related]